CN101836981B - 复方缬沙坦苯磺酸氨氯地平药物组合物及其制备方法 - Google Patents
复方缬沙坦苯磺酸氨氯地平药物组合物及其制备方法 Download PDFInfo
- Publication number
- CN101836981B CN101836981B CN200910228902XA CN200910228902A CN101836981B CN 101836981 B CN101836981 B CN 101836981B CN 200910228902X A CN200910228902X A CN 200910228902XA CN 200910228902 A CN200910228902 A CN 200910228902A CN 101836981 B CN101836981 B CN 101836981B
- Authority
- CN
- China
- Prior art keywords
- valsartan
- besylate tablet
- amlodipine besylate
- preparation
- amlodipine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910228902XA CN101836981B (zh) | 2009-12-01 | 2009-12-01 | 复方缬沙坦苯磺酸氨氯地平药物组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910228902XA CN101836981B (zh) | 2009-12-01 | 2009-12-01 | 复方缬沙坦苯磺酸氨氯地平药物组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101836981A CN101836981A (zh) | 2010-09-22 |
CN101836981B true CN101836981B (zh) | 2011-12-14 |
Family
ID=42740817
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910228902XA Active CN101836981B (zh) | 2009-12-01 | 2009-12-01 | 复方缬沙坦苯磺酸氨氯地平药物组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101836981B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103006651B (zh) * | 2013-01-09 | 2014-02-19 | 南京正大天晴制药有限公司 | 一种含奥美沙坦酯和氨氯地平的片剂及其制备方法 |
CN103479643A (zh) * | 2013-10-10 | 2014-01-01 | 沈阳药科大学 | 一种用于治疗高血压的复方制剂的制备方法 |
CN110286185A (zh) * | 2018-06-11 | 2019-09-27 | 南京济群医药科技股份有限公司 | 一种苯磺酸氨氯地平分散片溶出曲线测定方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101254180A (zh) * | 2008-03-28 | 2008-09-03 | 辽宁正鑫药物研究有限公司 | 一种内容物为半固体组合物的尼莫地平胶囊剂及制备方法 |
CN101346140A (zh) * | 2005-12-27 | 2009-01-14 | 韩美药品株式会社 | 含有右旋樟脑磺酸氨氯地平和辛伐他汀的复合制剂及其制备方法 |
-
2009
- 2009-12-01 CN CN200910228902XA patent/CN101836981B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101346140A (zh) * | 2005-12-27 | 2009-01-14 | 韩美药品株式会社 | 含有右旋樟脑磺酸氨氯地平和辛伐他汀的复合制剂及其制备方法 |
CN101254180A (zh) * | 2008-03-28 | 2008-09-03 | 辽宁正鑫药物研究有限公司 | 一种内容物为半固体组合物的尼莫地平胶囊剂及制备方法 |
Non-Patent Citations (1)
Title |
---|
韩钢等.尼群地平固体分散片的制备及其体外溶出度的测定.《华西药学杂志》.2003,第18卷(第1期), * |
Also Published As
Publication number | Publication date |
---|---|
CN101836981A (zh) | 2010-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103751193B (zh) | 包含利拉列汀和任选的sglt2抑制剂的药物组合物及其用途 | |
CN101984960B (zh) | 苯甲酸利扎曲普坦胶囊及其制备方法 | |
CN105147662A (zh) | 包含吡喃葡萄糖基二苯基甲烷衍生物的药物组合物及其药物剂型、制备方法与用途 | |
CN102319245A (zh) | 一种含有瑞格列奈和盐酸二甲双胍的组合物及其制备 | |
CN101816639B (zh) | 一种枸橼酸莫沙必利的片剂及其制备方法 | |
CN102499923B (zh) | 一种药物组合物、其制备方法及用途 | |
CN104940159A (zh) | 一种盐酸二甲双胍控释片及其制备方法与应用 | |
CN103181923B (zh) | 包含瑞格列奈的药物制剂及其制备方法 | |
CN101836981B (zh) | 复方缬沙坦苯磺酸氨氯地平药物组合物及其制备方法 | |
CN106176653A (zh) | 一种西格列汀的药物组合物 | |
CN101947219B (zh) | 一种复方替米沙坦苯磺酸氨氯地平药物组合物及其制备方法 | |
CN104940152A (zh) | 一种含有琥珀酸索利那新的药物组合物 | |
JP5671767B2 (ja) | メトホルミンおよびα−グリコシダーゼ抑制剤を含む経口製剤、およびその製造方法 | |
CN102600149B (zh) | 一种治疗糖尿病的药物组合物 | |
CN105030718B (zh) | 一种盐酸阿罗洛尔制剂及其制备方法 | |
CN101579323B (zh) | 丁苯酞缓释片及其制备方法 | |
CN100560069C (zh) | 一种米格列奈钙制剂及其检测方法 | |
CN103768068B (zh) | 一种波生坦药物组合物 | |
CN106551927A (zh) | 包含维格列汀和盐酸二甲双胍的药物组合物及其制备方法 | |
CN101199540B (zh) | 一种虎杖苷片剂及其制备方法 | |
CN103018190B (zh) | 一种药物制剂及其溶出度测定方法 | |
CN105168156B (zh) | 一种黄芩总黄酮分散片及其制造方法 | |
CN103191071B (zh) | 一种厄贝沙坦分散片及其制备方法 | |
CN109985013B (zh) | 一种尼群地平分散片及其制备方法 | |
CN102058602A (zh) | 一种稳定的含氯沙坦钾和氢氯噻嗪的口服固体制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: TIANJIN HANKANG PHARMACEUTICAL BIOTECHNOLOGY CO., Free format text: FORMER OWNER: YAN JIE Effective date: 20120210 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20120210 Address after: 300203, Tianjin Dagu South Road, respect 4, 3, Hexi District Patentee after: Tianjin Hankang Pharmaceutical Biotechnology Co., Ltd. Address before: 300203, Tianjin Dagu South Road, respect 4, 3, Hexi District Patentee before: Yan Jie |
|
TR01 | Transfer of patent right |
Effective date of registration: 20200119 Address after: 300409 No.88 Huashi Road, Beichen Science Park, Binhai New Area, Tianjin Patentee after: Tianjin Hanjia Pharmaceutical Technology Co., Ltd Address before: 300203, Tianjin Dagu South Road, respect 4, 3, Hexi District Patentee before: Tianjin Hankang Pharmaceutical Biotechnology Co., Ltd. |
|
TR01 | Transfer of patent right |